Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Celgene News

Home | Index > Business & Companies > Nasdaq 100 > Celgene

TAKE THIS POLL
Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

Research and Markets: Global Stem Cell and Advanced Technologies Market - Estimated to Be $88.3 Billion by 2014 24 Nov 2009 15:30 GMT
... ) has announced the addition of the " The stem ... Cell Therapeutics -- California Stem Cell -- Celgene Corporation -- Cellartis Ab -- Cellerant Therapeutics -- ...
Clavis Pharma and Clovis Oncology Sign $380 Million Partnership for the Development and Commercialisation of Anti-Cancer Agent CP-4126 24 Nov 2009 06:40 GMT
... OSLO, NORWAY and BOULDER, CO -- (MARKET WIRE) -- ... global oncology company, which was acquired by Celgene Corporation in 2008 for $2.9 billion. Earlier this ...
Clavis Pharma and Clovis Oncology Sign $380 Million Partnership for the Development and Commercialisation of 24 Nov 2009 06:52 GMT
... OSLO, NORWAY and BOULDER, CO -- (Marketwire) -- 11/24/09 ... global oncology company, which was acquired by Celgene Corporation in 2008 for $2.9 billion. Earlier this ...
Clavis Pharma and Clovis Oncology Sign $380 Million Partnership for the Development and Commercialisation of Anti-Cancer 24 Nov 2009 06:52 GMT
... * CP-4126 is a novel, lipid-conjugated form of gemcitabine designed ... global oncology company, which was acquired by Celgene Corporation in 2008 for $2.9 billion. Earlier this ...
Clavis Pharma and Clovis Oncology Sign $380 Million Partnership for the Development and Commercialis 24 Nov 2009 06:52 GMT
... Clavis Pharma and Clovis Oncology Sign $380 Million Partnership ... global oncology company, which was acquired by Celgene Corporation in 2008 for $2.9 billion. Earlier this ...

Agennix AG Reports Financial Results for Third Quarter and First Nine Months of 2009 23 Nov 2009 08:10 GMT
... Agennix AG Reports Financial Results for Third Quarter and First ... co-development and license agreement for satraplatin with Celgene Corporation. The termination became effective in September 2008 ...
Research and Markets: Cancer Therapies - Global Market Opportunities 19 Nov 2009 14:11 GMT
... ) has announced the addition of the " Cancer therapies ... (USA) -- Bristol-Myers Squibb Company (USA) -- Celgene Corporation (USA) -- Cell Therapeutics, Inc. (USA) -- ...
Innate Pharma, Celgene to collaborate to evaluate clinical potential of REVLIMID plus IPH 2101 18 Nov 2009 14:55 GMT
... Innate Pharma, Celgene to collaborate to evaluate clinical potential ... IPH) announced today that US-based biopharmaceutical company Celgene Corporation (NASDAQ: CELG) has agreed to collaborate with ...
Critical Alerts For Visa, Schlumberger, Celgene, Illumina, and American Water Works Released By Seven Summits Research 18 Nov 2009 14:52 GMT
... CHICAGO, Nov. 18 /PRNewswire/ -- Seven Summits Research issues ... Inc. (NYSE: V), Schlumberger Limited (NYSE: SLB), Celgene Corporation (Nasdaq: CELG), Illumina Inc. (Nasdaq: ILMN), and ...
ImmunoGen Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma 18 Nov 2009 14:55 GMT
... ImmunoGen Announces Encouraging Clinical Data with Its IMGN901 Compound ... 2006. Revlimid® is a registered trademark of Celgene Corporation. This press release includes forward-looking statements. For ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma 17 Nov 2009 17:50 GMT
... ), a biopharmaceutical company that develops targeted anticancer therapeutics, today ... 2006. Revlimid(R) is a registered trademark of Celgene Corporation. This press release includes forward-looking statements. For ...
News and FDA Updates for Celgene (NASDAQ:CELG), Genzyme (Nasdaq:GENZ) 16 Nov 2009 00:30 GMT
... News and FDA Updates for Celgene (NASDAQ:CELG), Genzyme (Nasdaq:GENZ) Pasadena, ... can be found on BioMedReports.Com On 11/13/09, Celgene Corporation (NASDAQ:CELG) announced its presentation at the Lazard ...
BiomedReports: News and FDA Updates for Celgene (NASDAQ:CELG), Genzyme (Nasdaq:GENZ) 16 Nov 2009 11:16 GMT
... Pasadena, CA, Nov 16, 2009 (M2 PRESSWIRE via COMTEX) ... can be found on BioMedReports.Com On 13/11/09, Celgene Corporation (NASDAQ:CELG) announced its presentation at the Lazard ...